Daytime Measurements Underestimate Nocturnal Oxygen Desaturations in Pulmonary Arterial and Chronic Thromboembolic Pulmonary Hypertension

被引:40
|
作者
Hildenbrand, Florian F.
Bloch, Konrad E. [2 ]
Speich, Rudolf [3 ]
Ulrich, Silvia [1 ]
机构
[1] Univ Zurich Hosp, Resp Clin, Div Pulm, CH-8091 Zurich, Switzerland
[2] Univ Zurich Hosp, Sleep Disorders Ctr, Dept Thorac & Cardiovasc Med, CH-8091 Zurich, Switzerland
[3] Univ Zurich Hosp, Clin Internal Med, CH-8091 Zurich, Switzerland
基金
瑞士国家科学基金会;
关键词
Chronic thromboembolic pulmonary hypertension; Pulmonary arterial hypertension; Sleep disordered breathing; CHEYNE-STOKES RESPIRATION; EXERCISE PERFORMANCE; HEART-FAILURE; SLEEP; GUIDELINES; DIAGNOSIS; THERAPY; DISEASE; ADULTS;
D O I
10.1159/000341182
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Nocturnal hypoxemia is important in precapillary pulmonary hypertension (pPH) as it worsens pulmonary hemodynamics. Whether daytime oxygen saturation (SpO(2)) predicts nocturnal hypoxemia in pPH patients has not been conclusively studied. Objectives: To investigate the prevalence of nocturnal hypoxemia in comparison to daytime SpO(2) and disease severity in ambulatory patients with pulmonary hypertension. Methods: Consecutive patients diagnosed with pPH classified as either pulmonary arterial (PAH) or chronic thromboembolic pPH (CTEPH) had daytime resting and exercise SpO(2) (at the end of a 6-min walk test); thereafter, they underwent overnight pulse oximetry at home. Functional class, pro-brain natriuretic peptide (pro-BNP) and the tricuspid pressure gradient were assessed. Results: Sixty-three patients [median (quartiles) age 62 (53; 71), 43 females] with PAH (n = 44) and CTEPH (n = 19) were included. The resting SpO(2), exercise SpO(2), and mean nocturnal SpO(2) were 95% (92; 96), 88% (81; 95), and 89% (85; 92), respectively. Forty-nine patients (77%) spent >10% of the night with SpO(2) <90% (desaturators), and 33 (52%) spent >50% of the night with SpO(2) <90% (sustained desaturators). The positive predictive values of daytime SpO(2) >90% for being a nocturnal nondesaturator or sustained nondesaturator were 25 and 53%, respectively. Nocturnal SpO(2) was negatively correlated with the tricuspid pressure gradient, but not with functional class, 6-min walk test, or pro-BNP. Conclusions: Nocturnal hypoxemia is very common in PAH and CTEPH despite often normal daytime SpO(2) and reflects disease severity. Nocturnal pulse oximetry should be considered in the routine evaluation of pPH patients and research should be directed toward the treatment of nocturnal desaturation in pPH. Copyright (c) 2012 S. Karger AG, Basel
引用
收藏
页码:477 / 484
页数:8
相关论文
共 50 条
  • [31] Differences in Ventilatory Inefficiency Between Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
    Zhai, Zhenguo
    Murphy, Kevin
    Tighe, Hannah
    Wang, Chen
    Wilkins, Martin R.
    Gibbs, J. Simon R.
    Howard, Luke S.
    CHEST, 2011, 140 (05) : 1284 - 1291
  • [32] Riociguat: A Novel Therapeutic Option for Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
    Mielniczuk, Lisa M.
    Swiston, John R.
    Mehta, Sanjay
    CANADIAN JOURNAL OF CARDIOLOGY, 2014, 30 (10) : 1233 - 1240
  • [33] Developments in pulmonary arterial hypertension-targeted therapy for chronic thromboembolic pulmonary hypertension
    Hadinnapola, Charaka
    Pepke-Zaba, Joanna
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2015, 9 (05) : 559 - 569
  • [34] Increased Antielastase Activity in Idiopathic Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
    Guo, Jingxu
    Lodge, Katharine
    Newnham, Michael
    Bunclark, Katherine
    Toshner, Mark
    Morrell, Nicholas W.
    Li, Wei
    AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2018, 59 (05) : 652 - 655
  • [35] BURDEN STUDY OF PULMONARY ARTERIAL HYPERTENSION AND CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION FOR COLOMBIA POPULATION
    Londono, D.
    Villaquiran, C.
    Duenas, R.
    Taborda, A.
    Rojas, K.
    Chamorro, C.
    CHEST, 2020, 157 (06) : 403A - 403A
  • [36] Anxiety and depression disorders in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
    Harzheim, Dominik
    Klose, Hans
    Pinado, Fabiola Pena
    Ehlken, Nicola
    Nagel, Christian
    Fischer, Christine
    Ghofrani, Ardeschir
    Rosenkranz, Stephan
    Seyfarth, Hans-Juergen
    Halank, Michael
    Mayer, Eckhard
    Gruenig, Ekkehard
    Guth, Stefan
    RESPIRATORY RESEARCH, 2013, 14
  • [37] Anxiety and depression disorders in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
    Dominik Harzheim
    Hans Klose
    Fabiola Peña Pinado
    Nicola Ehlken
    Christian Nagel
    Christine Fischer
    Ardeschir Ghofrani
    Stephan Rosenkranz
    Hans-Jürgen Seyfarth
    Michael Halank
    Eckhard Mayer
    Ekkehard Grünig
    Stefan Guth
    Respiratory Research, 14
  • [38] CXCL13 in idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
    Olsson, Karen M.
    Olle, Sandra
    Fuge, Jan
    Welte, Tobias
    Hoeper, Marius M.
    Lerch, Christian
    Maegel, Lavinia
    Haller, Hermann
    Jonigk, Danny
    Schiffer, Lena
    RESPIRATORY RESEARCH, 2016, 17
  • [39] Body fluid status in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
    Yogeswaran, A.
    Husain-Seyed, F.
    Tello, K.
    Sommer, N.
    Rako, Z. A.
    Ghofrani, H. A.
    Seeger, W.
    Richter, M. J.
    Gall, H.
    EUROPEAN HEART JOURNAL, 2022, 43 : 1910 - 1910
  • [40] Idiopathic Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension: Can We Be Certain?
    Berger, Gidon
    Azzam, Zaher S.
    Hardak, Emilia
    Tavor, Yonit
    Yigla, Mordechai
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2011, 13 (02): : 106 - 110